Pancreatic Cancer Recurrence in the Netherlands

UnknownOBSERVATIONAL
Enrollment

1,750

Participants

Timeline

Start Date

January 1, 2014

Primary Completion Date

July 1, 2023

Study Completion Date

July 1, 2023

Conditions
Pancreatic Ductal AdenocarcinomaPancreatic CancerPancreas CancerPDAC
Trial Locations (1)

3584 CX

RECRUITING

UMC Utrecht, Utrecht

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Amsterdam UMC, location VUmc

OTHER

collaborator

Erasmus Medical Center

OTHER

collaborator

Catharina Ziekenhuis Eindhoven

OTHER

collaborator

Radboud University Medical Center

OTHER

collaborator

University Medical Center Groningen

OTHER

collaborator

Jeroen Bosch Ziekenhuis

OTHER

collaborator

Leiden University Medical Center

OTHER

collaborator

Maastricht University Medical Center

OTHER

collaborator

Maasstad Hospital

OTHER

collaborator

Amphia Hospital

OTHER

collaborator

Onze Lieve Vrouwe Gasthuis

OTHER

collaborator

Reinier de Graaf Groep

OTHER

collaborator

Isala

OTHER

collaborator

St. Antonius Hospital

OTHER

lead

UMC Utrecht

OTHER

NCT04605237 - Pancreatic Cancer Recurrence in the Netherlands | Biotech Hunter | Biotech Hunter